文献速递消化、代谢与肾脏急症

减重手术与2型糖尿病及重度肥胖患者大血管病变结局的关联

Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity.
PubMed 文献 · JAMA · 2018-01-01
一句话结论观察性匹配队列显示,重度肥胖合并2型糖尿病患者接受减重手术与大血管事件5年发生率较低相关(2.1% vs 4.3%,HR 0.60),但需随机临床试验确认。

该回顾性匹配队列研究纳入美国4个整合健康系统中2005至2011年接受减重手术的重度肥胖(BMI≥35)合并2型糖尿病患者5301例,按站点、年龄、性别、BMI、糖化血红蛋白、胰岛素使用、糖尿病病程及既往医疗利用匹配14934例对照,随访至2015年9月。减重手术组5年大血管复合事件发生率为2.1%,非手术组为4.3%(HR 0.60,95%CI 0.42-0.86);冠状动脉疾病发生率分别为1.6%和2.8%(HR 0.64,95%CI 0.42-0.99);脑血管疾病发生率两组无显著差异(0.7% vs 1.7%,HR 0.69,95%CI 0.38-1.25)。作者认为减重手术与大血管结局风险较低相关,但需随机临床试验确认,并建议医务人员与重度肥胖合并2型糖尿病患者就减重手术在预防大血管事件中的潜在作用进行共同决策讨论。

要点

  • 在重度肥胖(BMI≥35)合并2型糖尿病患者中,减重手术组5年大血管复合事件发生率为2.1%,非手术组为4.3%(HR 0.60,95%CI 0.42-0.86)。
  • 减重手术组5年冠状动脉疾病发生率为1.6%,非手术组为2.8%(HR 0.64,95%CI 0.42-0.99)。
  • 两组5年脑血管疾病发生率无显著差异:减重手术组0.7% vs 非手术组1.7%(HR 0.69,95%CI 0.38-1.25)。
  • 该研究为回顾性匹配队列研究,作者结论为减重手术与大血管结局风险较低相关,但需随机临床试验确认。
  • 作者建议医务人员与重度肥胖合并2型糖尿病患者就减重手术在预防大血管事件中的潜在作用进行共同决策讨论。

适用人群与场景

  • 纳入:年龄19至79岁、重度肥胖(BMI≥35)合并2型糖尿病、2005至2011年在美国4个整合健康系统中接受减重手术的患者(n=5301),匹配非手术对照14934例。
  • 场景:非急诊/ICU场景,为门诊或住院择期减重手术人群的长期随访。

诊断标准与关键阈值

  • 大血管复合终点定义:冠状动脉疾病(急性心肌梗死、不稳定型心绞痛、经皮冠状动脉介入治疗或冠状动脉旁路移植术)或脑血管事件(缺血性卒中、出血性卒中、颈动脉支架置入或颈动脉内膜切除术)的首次发生。
  • 次要终点:冠状动脉疾病和脑血管结局分别分析。

研究设计与关键结果

  • 研究类型:回顾性、匹配队列研究,纳入美国4个整合健康系统,减重手术组5301例匹配非手术对照14934例,共20235例,随访至2015年9月。
  • 人群基线:平均(SD)年龄50(10)岁;女性比例手术组76%、非手术组75%;基线平均(SD)BMI手术组44.7(6.9)、非手术组43.8(6.7)。
  • 减重手术方式:76% Roux-en-Y胃旁路术,17%袖状胃切除术,7%可调节胃束带术。
  • 主要终点:5年大血管复合事件发生率手术组2.1% vs 非手术组4.3%(HR 0.60,95%CI 0.42-0.86)。
  • 次要终点:5年冠状动脉疾病发生率手术组1.6% vs 非手术组2.8%(HR 0.64,95%CI 0.42-0.99);5年脑血管疾病发生率手术组0.7% vs 非手术组1.7%(HR 0.69,95%CI 0.38-1.25),两组无显著差异。
  • 事件数:随访中位4.7年(四分位距3.2-6.2年)手术组发生106例大血管事件(脑血管37例、冠状动脉78例);随访中位4.6年(四分位距3.1-6.1年)匹配对照组发生596例事件(脑血管227例、冠状动脉398例)。

证据类型、等级与局限

  • 证据类型:回顾性、匹配队列研究(观察性研究)。
  • 局限:原文未报告局限性;作者在结论中写明「需在随机临床试验中确认」。

对床旁实践的改变

  • 作者认为,减重手术与重度肥胖合并2型糖尿病患者较低的大血管结局风险相关(观察性研究结果)。
  • 作者建议医务人员与重度肥胖合并2型糖尿病患者就减重手术在预防大血管事件中的潜在作用进行共同决策讨论。
  • 作者指出该发现需在随机临床试验中确认。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Macrovascular disease is a leading cause of morbidity and mortality for patients with type 2 diabetes, and medical management, including lifestyle changes, may not be successful at lowering risk.

OBJECTIVE: To investigate the relationship between bariatric surgery and incident macrovascular (coronary artery disease and cerebrovascular diseases) events in patients with severe obesity and type 2 diabetes.

DESIGN, SETTING, AND PARTICIPANTS: In this retrospective, matched cohort study, patients with severe obesity (body mass index ≥35) aged 19 to 79 years with diabetes who underwent bariatric surgery from 2005 to 2011 in 4 integrated health systems in the United States (n = 5301) were matched to 14 934 control patients on site, age, sex, body mass index, hemoglobin A1c, insulin use, observed diabetes duration, and prior health care utilization, with follow-up through September 2015.

EXPOSURES: Bariatric procedures (76% Roux-en-Y gastric bypass, 17% sleeve gastrectomy, and 7% adjustable gastric banding) were compared with usual care for diabetes.

MAIN OUTCOMES AND MEASURES: Multivariable-adjusted Cox regression analysis investigated time to incident macrovascular disease (defined as first occurrence of coronary artery disease [acute myocardial infarction, unstable angina, percutaneous coronary intervention, or coronary artery bypass grafting] or cerebrovascular events [ischemic stroke, hemorrhagic stroke, carotid stenting, or carotid endarterectomy]). Secondary outcomes included coronary artery disease and cerebrovascular outcomes separately.

RESULTS: Among a combined 20 235 surgical and nonsurgical patients, the mean (SD) age was 50 (10) years; 76% of the surgical and 75% of the nonsurgical patients were female; and the baseline mean (SD) body mass index was 44.7 (6.9) and 43.8 (6.7) in the surgical and nonsurgical groups, respectively. At the end of the study period, there were 106 macrovascular events in surgical patients (including 37 cerebrovascular and 78 coronary artery events over a median of 4.7 years; interquartile range, 3.2-6.2 years) and 596 events in the matched control patients (including 227 cerebrovascular and 398 coronary artery events over a median of 4.6 years; interquartile range, 3.1-6.1 years). Bariatric surgery was associated with a lower composite incidence of macrovascular events at 5 years (2.1% in the surgical group vs 4.3% in the nonsurgical group; hazard ratio, 0.60 [95% CI, 0.42-0.86]), as well as a lower incidence of coronary artery disease (1.6% in the surgical group vs 2.8% in the nonsurgical group; hazard ratio, 0.64 [95% CI, 0.42-0.99]). The incidence of cerebrovascular disease was not significantly different between groups at 5 years (0.7% in the surgical group vs 1.7% in the nonsurgical group; hazard ratio, 0.69 [95% CI, 0.38-1.25]).

CONCLUSIONS AND RELEVANCE: In this observational study of patients with type 2 diabetes and severe obesity who underwent surgery, compared with those who did not undergo surgery, bariatric surgery was associated with a lower risk of macrovascular outcomes. The findings require confirmation in randomized clinical trials. Health care professionals should engage patients with severe obesity and type 2 diabetes in a shared decision making conversation about the potential role of bariatric surgery in the prevention of macrovascular events.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Fisher DP, Johnson E, Haneuse S, et al. Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity. JAMA. 2018. PMID: 30326126. doi:10.1001/jama.2018.14619

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。